Company / Financials
Genprex, Inc. Financials
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$0
FY2024
Net Income
-$30.9M
FY2024 · -30.0% YoY
Profit Margin
-
FY2024 · net income / revenue
ROE
-416.1%
FY2024 · return on equity
Total Assets
$4.1M
FY2024
Total Debt
-
FY2024
Equity
$7.4M
FY2024
ROA
-748.3%
FY2024 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -24.42 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$0Net Income HistoryProfit after all expenses and taxes-$30.9M-30.0% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$31.1M-30.3% YoYSG&A Expense HistorySelling, general, and administrative expenses$13.4M+9.2% YoYR&D Expense HistoryResearch and development spending$17.6M+53.1% YoYInterest Expense HistoryCost of borrowing and debt obligations$1.9KIncome Tax HistoryTotal income tax expense$0EPS (Basic) HistoryBasic earnings per share-$22.56-13.9% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$0.51Shares Outstanding HistoryWeighted average diluted shares outstanding1.5M+23.5% YoY